0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 9,096 10,603 xbrli:pure xbrli:shares iso4217:GBP 08295361 2022-12-01 2023-11-30 08295361 2023-11-30 08295361 2022-11-30 08295361 2021-12-01 2022-11-30 08295361 2022-11-30 08295361 2021-11-30 08295361 bus:RegisteredOffice 2022-12-01 2023-11-30 08295361 bus:Director1 2022-12-01 2023-11-30 08295361 core:WithinOneYear 2023-11-30 08295361 core:WithinOneYear 2022-11-30 08295361 core:ShareCapital 2023-11-30 08295361 core:ShareCapital 2022-11-30 08295361 core:RetainedEarningsAccumulatedLosses 2023-11-30 08295361 core:RetainedEarningsAccumulatedLosses 2022-11-30 08295361 bus:SmallEntities 2022-12-01 2023-11-30 08295361 bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 08295361 bus:SmallCompaniesRegimeForDirectorsReport 2022-12-01 2023-11-30 08295361 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 08295361 bus:FullAccounts 2022-12-01 2023-11-30
COMPANY REGISTRATION NUMBER: 08295361
Norman Epstein Consulting Limited
Unaudited Financial Statements
30 November 2023
Norman Epstein Consulting Limited
Director's Report
Year ended 30 November 2023
The director presents his report and the unaudited financial statements of the company for the year ended 30 November 2023 .
Director
The director who served the company during the year was as follows:
Mrs K Kay
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 29 August 2024 and signed on behalf of the board by:
Mrs K Kay
Director
Registered office:
18 Kingsley Avenue
Borehanwood
Hertfordshire
England
WD6 4LY
Norman Epstein Consulting Limited
Statement of Income and Retained Earnings
Year ended 30 November 2023
2023
2022
Note
£
£
Administrative expenses
9,096
10,606
-------
--------
Operating loss
( 9,096)
( 10,606)
Other interest receivable and similar income
5
3
-------
--------
Loss before taxation
( 9,096)
( 10,603)
Tax on loss
-------
--------
Loss for the financial year and total comprehensive income
( 9,096)
( 10,603)
-------
--------
All the activities of the company are from continuing operations.
Norman Epstein Consulting Limited
Statement of Financial Position
30 November 2023
2023
2022
Note
£
£
Current assets
Cash at bank and in hand
73,759
64,859
Creditors: amounts falling due within one year
6
92,814
74,818
--------
--------
Net current liabilities
19,055
9,959
--------
-------
Total assets less current liabilities
( 19,055)
( 9,959)
--------
-------
Net liabilities
( 19,055)
( 9,959)
--------
-------
Capital and reserves
Called up share capital
7
1
1
Profit and loss account
( 19,056)
( 9,960)
--------
-------
Shareholders deficit
( 19,055)
( 9,959)
--------
-------
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
These financial statements were approved by the board of directors and authorised for issue on 29 August 2024 , and are signed on behalf of the board by:
Mrs K Kay
Director
Company registration number: 08295361
Norman Epstein Consulting Limited
Statement of Cash Flows
Year ended 30 November 2023
2023
2022
£
£
Cash flows from operating activities
Loss for the financial year
( 9,096)
( 10,603)
Adjustments for:
Other interest receivable and similar income
( 3)
Accrued expenses
80
1,250
Changes in:
Trade and other debtors
2,446
Trade and other creditors
17,916
( 1,164,909)
--------
------------
Cash generated from operations
8,900
( 1,171,819)
Interest received
3
-------
------------
Net cash from/(used in) operating activities
8,900
( 1,171,816)
-------
------------
Net increase/(decrease) in cash and cash equivalents
8,900
( 1,171,816)
Cash and cash equivalents at beginning of year
64,859
1,236,675
--------
------------
Cash and cash equivalents at end of year
73,759
64,859
--------
------------
Norman Epstein Consulting Limited
Notes to the Financial Statements
Year ended 30 November 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 18 Kingsley Avenue, Borehanwood, Hertfordshire, WD6 4LY, England.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Staff costs
The average number of persons employed by the company during the year, including the director, amounted to:
2023
2022
No.
No.
The aggregate payroll costs incurred during the year, relating to the above, were:
2023
2022
£
£
Wages and salaries
7,800
8,249
-------
-------
5. Other interest receivable and similar income
2023
2022
£
£
Interest on bank deposits
3
----
----
6. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
87,738
69,822
Accruals and deferred income
5,076
4,996
--------
--------
92,814
74,818
--------
--------
7. Called up share capital
Issued, called up and fully paid
2023
2022
No.
£
No.
£
8. Analysis of changes in net debt
At 1 Dec 2022
Cash flows
At 30 Nov 2023
£
£
£
Cash at bank and in hand
64,859
8,900
73,759
--------
-------
--------